Gut Microbiome Alterations Accompany Metabolic Normalization Following Bariatric Surgery in ROHHAD Syndrome.
Alessandra GranatoPaul MacDaragh RyanAnthony WongJill K HamiltonJayne S DanskaPublished in: JCEM case reports (2024)
Rapid onset obesity with hypoventilation, hypothalamic, and autonomic dysregulation (ROHHAD) syndrome in childhood is characterized by abrupt onset weight gain and dysautonomia with variable neuroendocrine involvement. In the absence of definitive disease-modifying therapies, the primary management strategy remains symptom control. This case report describes the first successful correction of obesity, dysautonomia, and metabolic derangement in a patient with ROHHAD following Roux-en-Y gastric bypass. Anthropometrics, metabolic profiling, and stool microbiome composition were assessed in a longitudinal fashion. In the 48-month period following surgery, the patient body mass index (BMI) reduced by 9.5 kg/m 2 and metabolic status improved, evidenced in weaning of insulin, and improved glycated hemoglobin, lipid profile, and hepatic enzymes. Chronic diarrhea resolved after surgery and prior to significant weight loss. Evaluation of stool bacterial composition and biomass demonstrated shifts in absolute abundance and taxonomic composition in longitudinal samples following surgery. This case demonstrates the potential efficacy of bariatric surgery in correcting the metabolic disruption of ROHHAD syndrome, producing long-term changes in gut microbiome composition and biomass.
Keyphrases
- weight loss
- bariatric surgery
- weight gain
- roux en y gastric bypass
- case report
- body mass index
- gastric bypass
- obese patients
- birth weight
- minimally invasive
- glycemic control
- type diabetes
- coronary artery bypass
- metabolic syndrome
- insulin resistance
- blood pressure
- heart rate
- physical activity
- coronary artery disease
- squamous cell carcinoma
- radiation therapy
- young adults
- anaerobic digestion
- high fat diet induced
- single cell
- human health
- quantum dots
- percutaneous coronary intervention
- antibiotic resistance genes